Guest Post by David Kliff, Diabetic Investor
The FDA approved Dexcom’s request for a non-adjunctive claim this week. It looks like a bad situation for conventional glucose monitors, and believe it or not is about to get worse. Here’s why.
What’s Important to Your Patient?
Male, 26 years of age, type 2 diabetes, obesity, hyperlipidemia, hypertension. Strong family history of type 2 diabetes with complications. Has been a patient since diagnosed 2 years ago. Has met with dietitian. Hasn’t made dietary changes, increased activity, or taken meds prescribed to lower his glucose. A1C 9.2% and rising every 3 months. He would also miss many of his appointments. Stated, “Nothing is going to bother me. Maybe it did my family, but that was a different time and it’s not going to happen to me. I’m going to go on enjoying my life.”
Read More »Kimberly Ward Part 1, Understanding the Accu-Chek Connect System
In part 1 of this Exclusive Interview, Kimberly Ward explains the goal and use of the Accu-Chek Connect System.
Read More »Will 2017 Bring Us the First Artificial Pancreas for Type 1 Diabetes?
System shows significant improvement in HbA1c compared to current best therapy available.
Read More »What’s Puzzling May Take a Simple Fix
16-year-old male, type 1 diabetes since 2 years of age, pump therapy. Eats about the same thing daily. Post prandials vary widely. When corrects for highs, gets low.
Read More »HbA1c Screening A Must In All Hospitals
Diabetes screening should be protocol test in all health centers, health fairs to prevent undiagnosed diabetes and avoid later complications.
Read More »Put the Needle in the Pill Box
Male, 32 years of age. Works erratic hours. Recently came up with a plan of how to remember to take his meds. He started setting up and taking his pill box with him. He has succeeded at taking his medications and taking them on time…all except his injectable medications.
Read More »Numbers Matter: 1-Hour Post Prandial Glucose Possible Predictor of Prediabetes Risk
Elevated 1-hour level proves significant despite 2-hour level within normal glucose tolerance range.
Read More »New Implantable CGM Receives Approval
Senseonics' Eversense™ 90-day implantable CGM approved in Europe.
Read More »Disaster Averted: Yes, You Can!
37-year-old woman has had type 1 diabetes since she was five years old. She was referred to me to help her manage her glucose levels because she wants to have a baby. She was wearing an insulin pump at the time, and had been for the past 20 years. Her glucose levels were very erratic. No pattern in sight.
Read More »